TRAF3-deficient B cells exhibit substantially enhanced survival, which in mice results in marked lymphoid organ enlargement, production of autoantibodies, and development of B cell lymphomas (BCL) with age (4). This evidence concerns the gene TRAF3 and B-cell non-Hodgkin lymphoma.